Transplantation Proceedings
Volume 32, Issue 1, Supplement 1 , Page 12 , February 2000

Protocol core biopsy (CADI): a surrogate marker for chronic rejection

  • S Yilmaz

      Affiliations

    • Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • E Taskinen

      Affiliations

    • Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • T Paavonen

      Affiliations

    • Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • P Häyry

      Affiliations

    • Transplantation Laboratory, University of Helsinki, and Helsinki University Central Hospital, Helsinki, Finland
    • Corresponding Author InformationAddress reprint requests to Pekka Häyry, MD, Transplantation Laboratory, University of Helsinki, PO Box 21 (Haartmaninkatu 3), FIN 00014 Helsinki, Finland
    • ,
  • for the Mycophenolate Mofetil ICM 1866 and IICR 023 Study Groups

References 

  1. Yilmaz S, Taskinen E, Paavonen T, et al.  Transplant International. 1992;5:85
  2. Yilmaz S, Paavonen T, Häyry P. Transplantation. 1992;53:823
  3. Isoniemi H, Krogerus L, von Willebrand E, et al.  Kidney Int. 1992;41:155
  4. Yilmaz S, Häyry P. Transplantation. 1993;56:1153
  5. Isoniemi H, Nurminen M, Tikkanen M, et al.  Transplantation. 1994;57:68
  6. Isoniemi H, Taskinen E, Häyry P. Transplantation. 1994;58:1195
  7. Kasiske BL, Kalil RS, Lee HS, et al.  Kidney Int. 1991;40:514
  8. Dimeny E, Wahlberg J, Larsson E, et al.  Clinical Transplant. 1994;9:79
  9. Häyry P, Yilmaz S, Taskinen E, et al.  In:  Lieberman R,  Mukherjee A editor. Principles of Drug Development in Transplantation and Autoimmunity, Austin, Texas. R. G. Landes Company; 1996;

PII: S0041-1345(00)00809-5

Transplantation Proceedings
Volume 32, Issue 1, Supplement 1 , Page 12 , February 2000

Article Tools